Literature DB >> 16331332

Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.

O Ju1, M Woolley, D Gordon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16331332     DOI： 10.1007/s10096-005-0063-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Rapid molecular typing of methicillin-resistant Staphylococcus aureus by PCR-RFLP.

Authors:  T A Wichelhaus; K P Hunfeld; B Böddinghaus; P Kraiczy; V Schäfer; V Brade
Journal:  Infect Control Hosp Epidemiol       Date:  2001-05       Impact factor: 3.254

2.  Molecular fingerprinting of fusidic acid- and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.

Authors:  A Norazah; V K E Lim; Y T Koh; M Y Rohani; H Zuridah; K Spencer; P P Ng; A G M Kamel
Journal:  J Med Microbiol       Date:  2002-12       Impact factor: 2.472

Review 3.  The use of rifampicin in staphylococcal infections--a review.

Authors:  J E Kapusnik; F Parenti; M A Sande
Journal:  J Antimicrob Chemother       Date:  1984-06       Impact factor: 5.790

4.  In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.

Authors:  M Foldes; R Munro; T C Sorrell; S Shanker; M Toohey
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

5.  Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections.

Authors:  J F Acar; F W Goldstein; J Duval
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

6.  Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus.

Authors:  C J Hackbarth; H F Chambers; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191
  6 in total
  8 in total

1.  In vitro efficacies and resistance profiles of rifampin-based combination regimens for biofilm-embedded methicillin-resistant Staphylococcus aureus.

Authors:  Hung-Jen Tang; Chi-Chung Chen; Kuo-Chen Cheng; Kuan-Ying Wu; Yi-Chung Lin; Chun-Cheng Zhang; Tzu-Chieh Weng; Wen-Liang Yu; Yu-Hsin Chiu; Han-Siong Toh; Shyh-Ren Chiang; Bo An Su; Wen-Chien Ko; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

2.  Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis.

Authors:  Rasoul Mirzaei; Mohammad Yousef Alikhani; Carla Renata Arciola; Iraj Sedighi; GholamReza Irajian; Elaheh Jamasbi; Rasoul Yousefimashouf; Kamran Pooshang Bagheri
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064

Review 3.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

4.  Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants.

Authors:  Xiangkuo Zheng; Renchi Fang; Chong Wang; Xuebin Tian; Jie Lin; Weiliang Zeng; Tieli Zhou; Chunquan Xu
Journal:  Infect Drug Resist       Date:  2021-04-21       Impact factor: 4.003

5.  Molecular Characteristics of Rifampin-Sensitive and -Resistant Isolates and Characteristics of rpoB Gene Mutations in Methicillin-Resistant Staphylococcus aureus.

Authors:  Yinjuan Guo; Bingjie Wang; Lulin Rao; Xinyi Wang; Huilin Zhao; Meilan Li; Fangyou Yu
Journal:  Infect Drug Resist       Date:  2021-11-04       Impact factor: 4.003

6.  Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

Authors:  Guy Thwaites; Cressida Auckland; Gavin Barlow; Richard Cunningham; Gerry Davies; Jonathan Edgeworth; Julia Greig; Susan Hopkins; Dakshika Jeyaratnam; Neil Jenkins; Martin Llewelyn; Sarah Meisner; Emmanuel Nsutebu; Tim Planche; Robert C Read; Matthew Scarborough; Marta Soares; Robert Tilley; M Estée Török; John Williams; Peter Wilson; Sarah Wyllie; A Sarah Walker
Journal:  Trials       Date:  2012-12-18       Impact factor: 2.279

7.  Therapeutic outcome of spinal implant infections caused by Staphylococcus aureus: A retrospective observational study.

Authors:  Oh-Hyun Cho; In-Gyu Bae; Song Mi Moon; Seong Yeon Park; Yee Gyung Kwak; Baek-Nam Kim; Shi Nae Yu; Min Hyok Jeon; Tark Kim; Eun Ju Choo; Eun Jung Lee; Tae Hyong Kim; Seong-Ho Choi; Jin-Won Chung; Kyung-Chung Kang; Jung Hee Lee; Yu-Mi Lee; Mi Suk Lee; Ki-Ho Park
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

8.  Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis.

Authors:  Huan Ma; Jie Cheng; Lengyue Peng; Yawen Gao; Guangli Zhang; Zhengxiu Luo
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.